Corvus Pharma (CRVS) – Analyst Ratings
-
Corvus Pharmaceuticals (CRVS) PT Lowered to $7 at Oppenheimer
-
Mizuho Securities Assumes Corvus Pharmaceuticals (CRVS) at Neutral
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to CRVS Stock Lookup